Key result
Global NRVD incidence climbs ~0.4% annually between 1990 and 2019.
Why the study?
Nonrheumatic valvular heart disease is an increasing public health concern among older people, and detailed epidemiological trends are crucial for allocating health care resources amidst population aging.
Observational
Yes
Effect estimate: EAPC 0.39 (95% CI 0.30-0.48)
The global burden of nonrheumatic valvular heart disease has increased over the past 3 decades, particularly in high-sociodemographic index countries and among older populations, with high systolic blood pressure identified as the most significant risk factor for mortality.
May warrant heightened NRVD surveillance in aging high-SDI populations; leaves open causal mechanisms and intervention targets.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) conducted an observational in Nonrheumatic valvular heart disease. Between 1990 and 2019, the global incidence of nonrheumatic valvular heart disease gradually increased, with an estimated annual percentage change of 0.39 (95% CI, 0.30-0.48).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: